Arthur Sillah1,2, Nathaniel F Watson3, Stephen M Schwartz4,5, David Gozal6, Amanda I Phipps4,5. 1. Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. asillah@uw.edu. 2. Epidemiology Program, Fred Hutchinson Research Cancer Research Center, Seattle, WA, USA. asillah@uw.edu. 3. Department of Neurology, University of Washington Medicine Sleep Center, University of Washington School of Medicine, Seattle, WA, USA. 4. Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. 5. Epidemiology Program, Fred Hutchinson Research Cancer Research Center, Seattle, WA, USA. 6. Department of Child Health, The University of Missouri School of Medicine, Columbia, MO, USA.
Abstract
PURPOSE: In vitro and animal models suggest that the physiological effects of sleep apnea could contribute to cancer risk, yet epidemiologic studies have been inconsistent. METHODS: We identified a cohort of adults diagnosed with sleep apnea between 2005 and 2014 using regional administrative databases. Linking this cohort to a population-based cancer registry, we identified first incident cancers diagnosed after sleep apnea diagnosis through 2015. We calculated age-sex standardized cancer incidence ratios (SIRs) to compare the observed number of cancers among those with sleep apnea with expected population estimates over a comparable period. RESULTS: Among 34,402 individuals with sleep apnea, 1,575 first incident cancers were diagnosed during follow-up (mean ± SD; 5.3 ± 2.0 years). Compared to the general population, cancer incidence (SIR 1.26, 95% CI 1.20-1.32) was elevated among sleep apnea patients. We observed significantly elevated incidence for kidney (SIR 2.24, 95% CI 1.82-2.72), melanoma (SIR 1.71, 95% CI 1.42-2.03), breast (SIR 1.43, 95% CI 1.76-2.00), and corpus uteri (SIR 2.80, 95% CI 2.24-2.47) while risk for lung (SIR 0.66, 95% CI 0.54-0.79) and colorectal cancer (SIR 0.71, 95% CI 0.56-0.89) was lower. CONCLUSION: These findings suggest an elevated cancer burden, particularly at certain sites, among individuals with diagnosed sleep apnea. Results should be interpreted with caution due to unmeasured confounders (e.g., BMI, diabetes).
PURPOSE: In vitro and animal models suggest that the physiological effects of sleep apnea could contribute to cancer risk, yet epidemiologic studies have been inconsistent. METHODS: We identified a cohort of adults diagnosed with sleep apnea between 2005 and 2014 using regional administrative databases. Linking this cohort to a population-based cancer registry, we identified first incident cancers diagnosed after sleep apnea diagnosis through 2015. We calculated age-sex standardized cancer incidence ratios (SIRs) to compare the observed number of cancers among those with sleep apnea with expected population estimates over a comparable period. RESULTS: Among 34,402 individuals with sleep apnea, 1,575 first incident cancers were diagnosed during follow-up (mean ± SD; 5.3 ± 2.0 years). Compared to the general population, cancer incidence (SIR 1.26, 95% CI 1.20-1.32) was elevated among sleep apneapatients. We observed significantly elevated incidence for kidney (SIR 2.24, 95% CI 1.82-2.72), melanoma (SIR 1.71, 95% CI 1.42-2.03), breast (SIR 1.43, 95% CI 1.76-2.00), and corpus uteri (SIR 2.80, 95% CI 2.24-2.47) while risk for lung (SIR 0.66, 95% CI 0.54-0.79) and colorectal cancer (SIR 0.71, 95% CI 0.56-0.89) was lower. CONCLUSION: These findings suggest an elevated cancer burden, particularly at certain sites, among individuals with diagnosed sleep apnea. Results should be interpreted with caution due to unmeasured confounders (e.g., BMI, diabetes).
Entities:
Keywords:
Cancer registry; Intermittent hypoxia; Medical records; Population health; Sleep apnea
Authors: Marta Torres; Noelia Campillo; Paula N Nonaka; Josep M Montserrat; David Gozal; Miguel Angel Martínez-García; Francisco Campos-Rodriguez; Daniel Navajas; Ramon Farré; Isaac Almendros Journal: Am J Respir Crit Care Med Date: 2018-11-01 Impact factor: 21.405
Authors: Laura K Barger; Shantha M W Rajaratnam; Wei Wang; Conor S O'Brien; Jason P Sullivan; Salim Qadri; Steven W Lockley; Charles A Czeisler Journal: J Clin Sleep Med Date: 2015-03-15 Impact factor: 4.062
Authors: Einar K Rofstad; Jon-Vidar Gaustad; Tormod A M Egeland; Berit Mathiesen; Kanthi Galappathi Journal: Int J Cancer Date: 2010-10-01 Impact factor: 7.396
Authors: Miguel Angel Martinez-Garcia; Francisco Campos-Rodriguez; Isaac Almendros; Francisco Garcia-Rio; Manuel Sanchez-de-la-Torre; Ramon Farre; David Gozal Journal: Am J Respir Crit Care Med Date: 2019-12-01 Impact factor: 21.405
Authors: Arthur Sillah; Nathaniel F Watson; Ulrike Peters; Mary L Biggs; F Javier Nieto; Christopher I Li; David Gozal; Timothy Thornton; Sonnah Barrie; Amanda I Phipps Journal: Cancer Epidemiol Date: 2021-11-17 Impact factor: 2.984
Authors: Dominic Wei Ting Yap; Nicole Kye Wen Tan; Benjamin Kye Jyn Tan; Yao Hao Teo; Veronique Kiak Mien Tan; Anna See; Song Tar Toh Journal: J Breast Cancer Date: 2022-03-10 Impact factor: 2.922
Authors: Tianyi Huang; Brian M Lin; Meir J Stampfer; Eva S Schernhammer; Richa Saxena; Shelley S Tworoger; Susan Redline Journal: Sleep Date: 2021-03-12 Impact factor: 5.849